Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China. (Q53383073)
Jump to navigation
Jump to search
scientific article published in August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China. |
scientific article published in August 2017 |
Statements
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China. (English)
1 reference
Nan Chen
1 reference
Jiaqi Qian
1 reference
Jianghua Chen
1 reference
Xueqing Yu
1 reference
Changlin Mei
1 reference
Chuanming Hao
1 reference
Gengru Jiang
1 reference
Hongli Lin
1 reference
Xinzhou Zhang
1 reference
Li Zuo
1 reference
Qiang He
1 reference
Ping Fu
1 reference
Xuemei Li
1 reference
Dalvin Ni
1 reference
Stefan Hemmerich
1 reference
Cameron Liu
1 reference
Lynda Szczech
1 reference
Anatole Besarab
1 reference
Thomas B Neff
1 reference
Kin-Hung Peony Yu
1 reference
Frank H Valone
1 reference
1 August 2017
1 reference
32
1 reference
8
1 reference
1373-1386
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference